MS is an inflammatory disease in which the balance between pro-inflammatory Th1/Th17 cells and anti-inflammatory CD4+FoxP3+ regulatory T cells is shifted toward a pro-inflammatory response. This evidence concerns the gene CD4 and myeloid sarcoma.